SPASLESS

Product Description

COMPOSITION: (per 4 ml ampoule)

• Phloroglucinol dihydrate …………………………………. 40 mg
  Equivalent to anhydrous Phloroglucinol …………………………………. 31.12 mg
• Trimethyl phloroglucinol …………………………………. 0.03 mg
• Excipients ……………………………………………………………….. q.s.

INDICATIONS:

• Symptomatic treatment of pain associated with spasms of the gastrointestinal tract, biliary tract, urinary tract, and gynecological disorders.

CONTRAINDICATIONS:

• Hypersensitivity to any component of the product.

DOSAGE AND ADMINISTRATION:

• Intravenous or intramuscular injection: 1–3 ampoules daily.

DRUG INTERACTIONS AND INCOMPATIBILITIES:

• Interaction with noramidopyrine.
• In the absence of compatibility studies, this product should not be mixed with other medicinal products for injection.

PACKAGING:

• Box of 1 blister × 6 ampoules × 4 ml